Healthcare | Heligan Group

What sets us apart

We take a sector-focused approach, providing deep expertise across pharma and life sciences, medical equipment and devices, and health and social care. Our unique perspective extends to healthcare IT which intersects all three areas, driving innovation and efficiency. With the freedom to challenge industry norms and deliver bold, insightful strategies, we provide deep expertise across pharma & life sciences, medical equipment & devices and health & social care.

Healthcare Trends & Considerations

M&A activity is rebounding as inflation and interest rates ease, lowering capital costs and boosting confidence. Healthcare remains strong, with a growing focus on prevention and outcomes. Expect more US-to-Europe M&A as American firms seek European expertise in wellness and IP. This shift signals rising interest in preventative care, natural products, and re-purposing existing therapies for new indications.

Expertise which leads the sector

Before we meet you, we identify buyers, investors, and industry dynamics, demonstrating deep expertise that builds trust. This knowledge-driven approach sets us apart, enabling us to deliver strategic, high-value outcomes for you that shape the sector.

We define sub-sectors, track market trends, and analyse key transactions to ensure we speak the same language as you.

M&A activity in the UK Healthcare sector: look back at February 2025

Find out more about the latest M&A deals, insights and opinion relating to the UK's Healthcare sector.

Download report

Unlock UK Healthcare M&A insights

Discover the key trends which shaped UK Healthcare M&A in 2024. Explore deal drivers, resilient sub-sectors, and the future outlook for private equity and corporate activity. Download the full report to find out more.